Australia's most trusted
source of pharma news
Wednesday, 1 July 2026
Wednesday, 1 July 2026
Subscribe
Login
Minister fails to rule out PBS delisting
Mark Butler has failed to use his ministerial powers to rule out a savage 40 per cent price cut that could see two major drugs that combined earned $370M on the PBS delisted - instead he's flicked the problem to the PBAC.
Cancer patients pick No. 1 pharma
Companies selected for best corporate reputation but industry overall scolded for failing to improve access to innovative medicines
TODAY
Half left uncovered by PBS
Patients Australia survey finds people are often prescribed drugs not covered by the PBS with many delaying treatment due to cost
TODAY
Government expands vax funding
Data showing previously ineligible groups are at risk has prompted an expansion of the funded vaccine programs
TODAY
Six Aussie Country Leaders in limbo
A spate of departures from country leadership roles across ANZ has left six top operators in limbo and a number of job openings
30 June
Troubled drug faces revocation
Concerns over a registrational trial have seen overseas authorities recommend removing approval for this PBS-listed drug
30 June
J&J argues against 'far greater evil'
The pharma giant is seeking clarification on the size of a class action suit against it, while the applicants argue it would just produce 'useless information'
30 June
Latest Jobs
Customer Service RepresentativeTerritory ManagerTerritory ManagerCustomer Service RepresentativeCustomer Service RepresentativeTerritory ManagerTerritory Manager - SterilisationWarehouse Assistant37 more...
Pharma in Focus Jobs
Marketing & Communications (2)
Sales & Customer Relations (22)
- Customer Service Representative - Frenchs Forest
- Territory Manager - Melbourne
- Territory Manager - Auckland
- Customer Service Representative - Melbourne
- Customer Service Representative - Macquarie Park
- Territory Manager - Sydney
- Territory Manager - Sterilisation - Melbourne
- Customer Service Representative - Sydney
- Customer Service Representative - Victoria - Mulgrave
- Customer Service Representative - Perth
- Territory Manager - Auckland
- Senior Sales Manager - Sydney
- Clinical Account Manager - Melbourne
- Account Manager - Sydney
- Territory Manager - Sydney
- Pharmaceutical Sales Representative - Brisbane
- Customer Service Representative - Macquarie Park
- Customer Service Representative - Macquarie Park
- Senior Director, Business Development - Clinical Research - Tokyo, Japan
- Senior Director, Business Development - Clinical Research (Tokyo Based) - Tokyo, Japan
- Equipment Sales Specialist - Dental - Sydney
- Territory Manager - Melbourne
Access & Reimbursement (2)
- Head of Access, Sustainability & External Engagement - Melbourne
- Associate Director / Senior Manager, Market Access (ANZ) - Melbourne
Clinical & Medical, R&D (6)
- Medical Reception - West Perth
- Clinical Account Manager - Melbourne
- Senior Medical Science Liaison - Sydney
- Associate Director, Clinical Operations (Japan) - Tokyo, Japan
- Senior Director, Business Development - Clinical Research - Tokyo, Japan
- Senior Director, Business Development - Clinical Research (Tokyo Based) - Tokyo, Japan
Regulatory, Pharmacovigilance & QA (6)
- Senior Quality Assurance Associate - Randwick
- Regulatory Affairs Manager - Belrose
- Country Head, Regulatory Affairs, ANZ - Melbourne
- Senior Quality Assurance Manager - Sydney
- Quality Control Systems Specialist - Tullamarine
- Director - Regulatory Affairs - Melbourne
Executive Roles (5)
- Associate Director / Senior Manager, Market Access (ANZ) - Melbourne
- Associate Director, Clinical Operations (Japan) - Tokyo, Japan
- Senior Director, Business Development - Clinical Research - Tokyo, Japan
- Senior Director, Business Development - Clinical Research (Tokyo Based) - Tokyo, Japan
- Director - Regulatory Affairs - Melbourne
Other (11)
- Warehouse Assistant - Macquarie Park
- Pharmacy Assistant - Toongabbie
- Loan Kit Technician - Macquarie Park
- Finance Business Partner - North Ryde
- HR Consultant - Melbourne
- Senior SFE Analyst - Sydney
- Web Producer - Sydney
- Manufacturing Process Engineer - Blacktown
- QC Analyst - Microbiology - Melbourne
- Lab Technician - Victoria
- Senior Recruitment Consultant - Victoria
The PBS at its best, Mark. Really?
The Health Minister has curiously used a therapy that took almost five years to reach patients as an example of the PBS at its best
29 June
'Policy lag tax' hurting patients
The true cost of policy delays is costing patients and the payment due is far more expensive than cash dollars
30 June
TGA win lands just in time
This company has earned the regulator's nod for a drug which will be considered by the PBAC when it meets early next month
30 June
10 drugs score July PBS listings
The 10 PBS listings announced by Butler includes 2 new labels for one drug, and a drug yet to be recommended by the PBAC
29 June
Double PBS win for Novo
Two long-awaited drugs to join the scheme - one recommended by the PBAC three years ago and another TGA approved in 2017
29 June
NEXT-level Summit agenda reveal
The Day 1 Agenda for NEXT Pharma Summit Australia is out promising a no-holds-barred deep dive into the state of the industry
29 June
$59M drug under threat
The TGA has approved two new meds plus the first generics of two drugs - one which made over $59M on the PBS last year
29 June Approvals Action
Two days, two big deals for Arrotex
Company steams on, signing yet another deal - this time bringing an innovative medicine to ANZ in a space dominated by Big Pharmas
26 June
Aussie redundancies keep piling up
ICYMI: Another Big Pharma has announced it's downsizing its local team plus the other top stories this week
26 June Your Week in 5 Minutes
Pharma's feeling slightly less gloomy
Despite unrelenting headwinds the industry's mood is improving, inching away from negative sentiment into neutral territory
26 June
Why pharma strategies are failing
The gap between strategic intent and execution is widening as demand for transformation grows faster than leadership capacity
26 June
Lilly says 'No' to Aussie drug launch
This new drug will not reach Aust in the foreseeable future as Lilly continues its stance against the nation's reimbursement system
25 June
Look who's moving its HQ to the US
Australian radiopharma is setting up its global headquarters in Boston as it takes on the big guns, including Novartis
26 June
Arrotex inks first-to-market deal
Arrotex has lost its CEO, but the deals keep coming with an exclusive agreement to bring first-to-market therapy eye to Australia
25 June